Acadian Asset Management
IMNM icon

Acadian Asset Management’s Immunome IMNM Stock Holding History

Acadian Asset Management’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,237
Closed -$47K – 1879
2024
Q3 		$47K Buy
+3,237
New +$46K ﹤0.01% 1803
2024
Q2 		– Sell
-133,438
Closed -$3.29M – 1824
2024
Q1 		$3.29M Buy
133,438
+114,433
+602% +$2.32M 0.01% 558
2023
Q4 		$202K Sell
19,005
-30,707
-62% -$255K ﹤0.01% 1236
2023
Q3 		$414K Buy
+49,712
New +$365K ﹤0.01% 1048

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management's IMNM Position: Q4 2024 in Review

Acadian Asset Management sold out of Immunome (IMNM) in Q4 2024, closing a stake of 3,237 shares — an estimated $47K sold.

Acadian Asset Management first reported a position in IMNM in Q3 2023 and held it in 4 quarters. The position peaked at $3.29M in Q1 2024. 120 funds tracked by Wall St. Rank hold IMNM as of Q4 2024.

  • Acadian Asset Management reported no remaining Immunome position as of Q4 2024 after selling out during the quarter.
  • Acadian Asset Management sold 3,237 Immunome shares in Q4 2024, an estimated $47K.
  • Acadian Asset Management first reported a position in Immunome in Q3 2023 and held it in 4 quarters.
  • Acadian Asset Management's Immunome position peaked at $3.29M in Q1 2024.
  • 120 funds tracked by Wall St. Rank held Immunome as of Q4 2024.

Based on Acadian Asset Management's 13F filing for Q4 2024, filed 11 Feb 2025.